$3.19
00.00%
At Close: -
$3.34
0.154.83%
After Hours: 7:59 PM EDT
15 minutes delayed
NeuroBo Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NeuroBo Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-1.85 | $-1.12 | -65.2 % |
Mar 2024 | 2024-05-09 | $-1.32 | $-1.10 | -20.0 % |
Dec 2023 | 2024-03-28 | $-1.02 | $-0.78 | -30.8 % |
Sep 2023 | 2023-11-13 | $-0.72 | $-0.88 | 18.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
NeuroBo Pharmaceuticals (NRBO) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-1.85, which missed the estimate of $-1.12.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.